British Cardiac Society Working Group on the definition of myocardial infarction

Heart

Volumn 90, Issue 6, 2004, Pages 603-609

  Fox, K A A ^a   Birkhead, J ^b   Wilcox, R ^c   Knight, C ^d   Barth, J ^e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NORTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d LONDON CHEST HOSPITAL   (United Kingdom)

^e LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; TROPONIN;

CARDIOLOGY; CARDIOVASCULAR RISK; CELL DEATH; CLINICAL PRACTICE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; HEART INFARCTION; HUMAN; IMAGING; ISCHEMIC HEART DISEASE; MUSCLE CELL; NOMENCLATURE; ORGANIZATION; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; TECHNIQUE; UNSTABLE ANGINA PECTORIS; WORLD HEALTH ORGANIZATION;

EID: 2442698835     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.038679     Document Type: Review

References (34)

1. Anon, Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
2. Fox KAA, Goodman SG, Klein W, et al. Management of acute coronary syndromes. Variations in practice and outcome: findings from the global registry of acute coronary events (GRACE). Eur Heart J 2002;23:1177-89.
3. Collinson J, Flather MD, Fox KAA, et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK). Eur Heart J 2000;21:1450-7.
4. Alpert JS. The not so obvious truth. Eur Heart J 2000;21:180-1.
5. Antman EM, Cohen M, Bernink PJLM, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.
6. Christopher B, Granger, Robert J, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003;163:2345-53.
7. Ferguson JL, Beckett GJ, Stoddart M, et al. Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction. Heart 2002;88:343-7.
8. Apple FS. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem 1999;45:18-20.
9. Apple F, Wu A, Jaffe A. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardiol infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002;144:981-6.
10. Thygesen KA, Alpert JS. The definitions of acute coronary syndrome, myocardial infarction and unstable angina. Curr Cardiol Rep 2002;3:268-72.
11. Apple FS, Quist HE, Doyle PJ, et al. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003;49:1331-6.
12. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9.
13. Remppis A, Ehlermann P, Giannitsis E, et al. Cardiac troponin T levels at 96 hours reflect myocardial infarct size: a pathoanatomical study. Cardiology 2000;93:249-53.
14. Rao ACR, Collinson PO, Canepa-Anson R, et al. Troponin T measurement after myocardial infarction can identify left ventricular ejection of less than 40%. Heart 1998;80:223-5.
15. Akkerhuis KM, Alexander JH, Tardiff BE, et al. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation 2002;105:554-6.
16. Simoons ML, van den Brand M, Lincoff M, et al. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J 1999;20:112-9.
17. Herrmann J, von Birgelen C, Haude M, et al. Prognostic implication of cardiac troponin T increase following stent implantation. Heart 2002;87:549-53.
18. Cantor WJ, Newby LK, Christenson RH, et al., for the SYMPHONY and 2nd SYMPHONY Cardiac Markers Substudy Investigators. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002;39:1738-44.
19. Nallamothu BK, Chetcuti S, Mukherjee D, et al. Prognostic implication of troponin I elevation after percutaneous coronary intervention. Am J Cardiol 2003;91:1272-4.
20. Fuchs S, Kornowski R, Mehran R, et al. Prognostic value of cardiac troponin I levels following catheter-based interventions. Am J Cardiol 2000;85:1077-82.
21. Saucedo JF, Mehran R, Dangas G, et al. Long-term clinical events following creatine kinase myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 2000;35:1134-41.
22. Ellis SG, Chew D, Chan A, et al. Death following creatine kinase-MB elevation after coronary intervention. Circulation 2002;106:1205-10.
23. Landesberg G, Shatz V, Akopnik I, et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 2003;42:1547-54.
24. Panteghini M, Pagani F, Yeo K-TJ, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentration. Clin Chem 2004;50:327-32.
25. Marso SP, Bliven BD, House JA, et al. Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality. Eur Heart J 2003;24:1323-8.
26. Morrow DA, Cannon CP, Rifait N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001;286:2405-12.
27. Morrow DA, Rifai N, Sabatine MS, et al. Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes. Clin Chem 2003;49:1396-8.
28. Morrow DA, Rifai N, Tanasijevic MJ, et al. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a thrombolysis in myocardial infarction (TIMI) 11B substudy. Clin Chem 2000;46:453-60.
29. Venge P, Lagerqvist B, Diderholm E, et al. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 2002;89:1035-41.
30. Venge P, Johnston N, Lagerqvist B, et al. Clinical and analytical performance of the Liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy. Clin Chem 2003;49:880-6.
31. Uettwiller-Geiger D, Wu AH, Apple FS, et al. Multicentre evaluation of an automated assay for troponin I. Clin Chem 2002;48:869-76.
32. Lewis JS Jr, Taylor JF, Miklos AZ, et al. Clinical significance of low-positive troponin I by AxSYM and ACS:180. Am J Clin Pathol 2001;116:396-402.
33. Kao JT, Wong IL, Lee JY, et al. Comparison of Abbott AxSYM, Behring Opus Plus, DPC Immulite and Ortho-Clinical Diagnostics Vitro ECi for measurement of cardiac troponin I. Ann Clin Biochem 2001;38:140-6.
34. Anon. Annual report April 2002 to March 2003. Bristol: UK NEQAS for Antibiotic Assays, 2003.